MRNA
Moderna Inc
$63.65
0.02 (0.03%) Today
0.01 (0.02%) After-hours
— up— down
Market Cap
$25.41B+136.7%
Revenue (TTM)
$2.22B-27.6%
Net Income (TTM)
$-3,168,249,113
$-3,168,249,113EPS (TTM)
-7.98
-7.98Shares Out
396.79M
396.79MOpen
$63.80
$63.80Previous Close
$63.67
$63.67Day Range
$62.33 – $65.33
$62.33 – $65.3352-Week Range
$22.28 – $85.60
$22.28 – $85.60Beta
0.96
0.96Volume
8.16M
8.16MAvg Volume
7.06M
7.06MAnalyst Rating
Hold
HoldExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout MRNA
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
Related
News
N/AN/AN/A
N/A
Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?
Yahoo · 3d ago
FDA approval of mFLUSIVA highlights Moderna’s position in mRNA market
Yahoo · 3d ago
RocketLab Rises on Space Interest; Moderna Moves on Flu Shot | Stock Movers
Yahoo · 3d ago

Moderna: I'm Still On Sell, But Here's What Would Change My Mind
SeekingAlpha · 3d ago
Moderna (MRNA) Q2 2026 Earnings Call Transcript
Yahoo · 5d ago